Perioperative Management of Catecholamine-Secreting Glomus Jugulare Tumors
Abstract To treat patients with a catecholamine-secreting glomus jugulare tumor, perioperative management is important. Perioperative catecholamine hypersecretion causes severe problems in the treatment of a catecholamine-secreting glomus tumor. Therefore, a precise therapeutic strategy and perioper...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2014-06-01
|
Series: | Journal of Neurological Surgery Reports |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0034-1378154 |
id |
doaj-91764323555b4767b3d063020299ce53 |
---|---|
record_format |
Article |
spelling |
doaj-91764323555b4767b3d063020299ce532020-11-25T01:58:19ZengGeorg Thieme Verlag KGJournal of Neurological Surgery Reports2193-63582193-63662014-06-017501e170e17410.1055/s-0034-1378154Perioperative Management of Catecholamine-Secreting Glomus Jugulare TumorsYu Teranishi0Michihiro Kohno1Shigeo Sora2Hiroaki Sato3Naoko Haruyama4Department of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital, Tokyo, JapanDepartment of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital, Tokyo, JapanDepartment of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital, Tokyo, JapanDepartment of Neurosurgery and Stroke Center, Tokyo Metropolitan Police Hospital, Tokyo, JapanDepartment of Anesthesiology, Tokyo Metropolitan Police Hospital, Tokyo, JapanAbstract To treat patients with a catecholamine-secreting glomus jugulare tumor, perioperative management is important. Perioperative catecholamine hypersecretion causes severe problems in the treatment of a catecholamine-secreting glomus tumor. Therefore, a precise therapeutic strategy and perioperative management are required through collaboration of the endocrinology, anesthesiology, and endocrine surgery departments . We describe our perioperative management for catecholamine-secreting glomus jugulare tumor. The patient was a 31-year-old woman with a 50-mm glomus jugulare tumor and a significantly elevated plasma noradrenaline level of 21,165 pg/ml. Before the surgery, oral α − blocker administration was initiated for ∼ 3 months, and her body weight increased from 52 kg at the time of examination to 54.2 kg. Coil embolization of the tumor vessel was performed 1 week before surgery, and the intense tumor stain was reduced by 90%. The patient underwent almost total removal of the tumor via mastoidectomy with high cervical exposure via the transsigmoid approach. Postoperatively, plasma noradrenaline decreased markedly. Preoperative pharmacologic stabilization and peri- and postoperative anesthetic management are essential for the treatment of a catecholamine-secreting glomus jugulare tumor.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0034-1378154glomus jugular tumorpheochromocytomacatecholaminesurgical strategyskull base surgery |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yu Teranishi Michihiro Kohno Shigeo Sora Hiroaki Sato Naoko Haruyama |
spellingShingle |
Yu Teranishi Michihiro Kohno Shigeo Sora Hiroaki Sato Naoko Haruyama Perioperative Management of Catecholamine-Secreting Glomus Jugulare Tumors Journal of Neurological Surgery Reports glomus jugular tumor pheochromocytoma catecholamine surgical strategy skull base surgery |
author_facet |
Yu Teranishi Michihiro Kohno Shigeo Sora Hiroaki Sato Naoko Haruyama |
author_sort |
Yu Teranishi |
title |
Perioperative Management of Catecholamine-Secreting Glomus Jugulare Tumors |
title_short |
Perioperative Management of Catecholamine-Secreting Glomus Jugulare Tumors |
title_full |
Perioperative Management of Catecholamine-Secreting Glomus Jugulare Tumors |
title_fullStr |
Perioperative Management of Catecholamine-Secreting Glomus Jugulare Tumors |
title_full_unstemmed |
Perioperative Management of Catecholamine-Secreting Glomus Jugulare Tumors |
title_sort |
perioperative management of catecholamine-secreting glomus jugulare tumors |
publisher |
Georg Thieme Verlag KG |
series |
Journal of Neurological Surgery Reports |
issn |
2193-6358 2193-6366 |
publishDate |
2014-06-01 |
description |
Abstract
To treat patients with a catecholamine-secreting glomus jugulare tumor, perioperative management is important. Perioperative catecholamine hypersecretion causes severe problems in the treatment of a catecholamine-secreting glomus tumor. Therefore, a precise therapeutic strategy and perioperative management are required through collaboration of the endocrinology, anesthesiology, and endocrine surgery departments . We describe our perioperative management for catecholamine-secreting glomus jugulare tumor. The patient was a 31-year-old woman with a 50-mm glomus jugulare tumor and a significantly elevated plasma noradrenaline level of 21,165 pg/ml. Before the surgery, oral α − blocker administration was initiated for ∼ 3 months, and her body weight increased from 52 kg at the time of examination to 54.2 kg. Coil embolization of the tumor vessel was performed 1 week before surgery, and the intense tumor stain was reduced by 90%. The patient underwent almost total removal of the tumor via mastoidectomy with high cervical exposure via the transsigmoid approach. Postoperatively, plasma noradrenaline decreased markedly. Preoperative pharmacologic stabilization and peri- and postoperative anesthetic management are essential for the treatment of a catecholamine-secreting glomus jugulare tumor. |
topic |
glomus jugular tumor pheochromocytoma catecholamine surgical strategy skull base surgery |
url |
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0034-1378154 |
work_keys_str_mv |
AT yuteranishi perioperativemanagementofcatecholaminesecretingglomusjugularetumors AT michihirokohno perioperativemanagementofcatecholaminesecretingglomusjugularetumors AT shigeosora perioperativemanagementofcatecholaminesecretingglomusjugularetumors AT hiroakisato perioperativemanagementofcatecholaminesecretingglomusjugularetumors AT naokoharuyama perioperativemanagementofcatecholaminesecretingglomusjugularetumors |
_version_ |
1724970346813063168 |